Evidence map›Paper›PMID 42310390›Full record

ArticleEMBO molecular medicine2026

Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndrome.

Martin Killian, Suzanne K Shoffner-Beck, Timon Damelang, Kevin John Selva, Kade E Wong, Samantha K Davis, Ebene R Haycroft, Bruce D Wines, P Mark Hogarth, Stephen J Kent and 26 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Martin Killian *Team GIMAP, CIRI, Université de Lyon, UJM, UCBL1, INSERM U1111, CNRS UMR530, Saint-Etienne, France. martin.killian@chu-st-etienne.fr.ORCID 0000-0001-7115-3248
Suzanne K Shoffner-Beck *Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0003-0010-6318
Timon DamelangDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Kevin John SelvaDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Kade E WongDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Samantha K DavisDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Ebene R HaycroftDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Bruce D WinesImmune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.
P Mark HogarthImmune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.
Stephen J KentDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0002-8539-4891
Lucile GrangeTeam GIMAP, CIRI, Université de Lyon, UJM, UCBL1, INSERM U1111, CNRS UMR530, Saint-Etienne, France.
Baptiste GramontTeam GIMAP, CIRI, Université de Lyon, UJM, UCBL1, INSERM U1111, CNRS UMR530, Saint-Etienne, France.
Flora ScheinDepartment of Internal Medicine, Saint-Etienne University Hospital, Saint-Etienne, France.
Héloïse Munoz-PonsDepartment of Internal Medicine, Saint-Etienne University Hospital, Saint-Etienne, France.
Isabelle GuichardDepartment of Internal Medicine, Saint-Etienne University Hospital, Saint-Etienne, France.ORCID 0000-0003-1573-7171
Jean-Baptiste GaultierDepartment of Internal Medicine, Saint-Etienne University Hospital, Saint-Etienne, France.
Anne-Emmanuelle BergerLaboratory of Immunology, Saint-Etienne University Hospital, Saint-Etienne, France.
Alice HaccourtLaboratory of Immunology, Saint-Etienne University Hospital, Saint-Etienne, France.
Blandine ChanutTeam GIMAP, CIRI, Université de Lyon, UJM, UCBL1, INSERM U1111, CNRS UMR530, Saint-Etienne, France.
Fabienne JospinTeam GIMAP, CIRI, Université de Lyon, UJM, UCBL1, INSERM U1111, CNRS UMR530, Saint-Etienne, France.
Alexis BocquetDepartment of Internal Medicine, Grenoble University Hospital, Grenoble, France.
Laurence BouilletDepartment of Internal Medicine, Grenoble University Hospital, Grenoble, France.
Marc RuivardDepartment of Internal Medicine, Hôpital Estaing, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
Yvan JamillouxDepartment of Internal Medicine, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0001-5249-3650
Pascal SèveDepartment of Internal Medicine, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0003-3070-3842
Isabelle DurieuDepartment of Internal and Vascular Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Quitterie ReynaudDepartment of Internal and Vascular Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Jean-Christophe LegaDepartment of Internal and Vascular Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Amélie ServettazDepartment of Internal Medicine, Clinical Immunology, Reims University Hospital, and University Reims Champagne Ardenne, IRMAIC, Reims, France.
Hubert MarotteDepartment of Rheumatology, Saint-Etienne University Hospital, Saint-Etienne, France.
Pascal CathébrasDepartment of Internal Medicine, Saint-Etienne University Hospital, Saint-Etienne, France.
Rémy HarléUnité de Recherche Clinique, Saint-Etienne University Hospital, Saint-Etienne, France.ORCID 0009-0005-3404-3476
Edouard OllierUniversité Jean Monnet Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, Saint-Etienne, France.
Stéphane PaulTeam GIMAP, CIRI, Université de Lyon, UJM, UCBL1, INSERM U1111, CNRS UMR530, Saint-Etienne, France.ORCID 0000-0002-8830-4273
Kelly B Arnold *Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Amy W Chung *Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia. awchung@unimelb.edu.au.ORCID 0000-0003-0020-9704

Funding

DHAC | National Health and Medical Research Council (NHMRC) Investigator Grant #2008092Groupe Pasteur Mutualité (GPM) Villa M 2019 GrantInstitut Servier (Servier Institute) Bourse de Recherche 2019Ministère de la Santé (Ministry of Public Health) AURA PHRCI-16-006
6 · The paper itself

Abstract

Sjögren's Syndrome (SjS) has historically been associated with classical anti-Ro60/SSA, Ro52/SSA and La/SSB, however they are lacking in one third of the patients, which induces delays in diagnosis, and their disease-contributing role is debated. Here we have applied a SjS-tailored Systems Serology approach to a cohort of 58 SjS and 16 non-SjS sicca syndrome patients, and 40 healthy individuals, involving a multiplex assay measuring antibody isotype, subclass, Fc Receptor and complement engagement to 14 SjS-related autoantigens, an antibody-glycosylation profiling assay and a phagocytosis cell-based assay. Via a machine learning approach, we have identified unique autoantibody signatures, including classical and non-classical autoantigens-related features especially involving autoantigen-specific Fc Receptor binding, with apparent functional consequences. These findings provide interesting insights into the autoantibody responses in SjS, possibly paving the way for improved diagnostics, especially in difficult-to-diagnose patients (e.g., seronegative SjS and non-SjS sicca syndrome patients), and novel therapeutic options targeting autoantibody-specific Fc/Fc Receptor-related effector functions.

Indexed as

AutoantibodiesReceptors, FcSjogren's SyndromeAutoantigensFemaleHumansAutoantibodiesAutoantigensReceptors, Fc

Identifiers

PMID42310390
PMCPMC13365422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.